On World Clinical Trials Day—observed annually on 20 May—Evangelia Koraki, President of HACRO (Hellenic Association for Clinical Research Organisations) and CEO & Chair of CORONIS Research, highlighted the vital role of clinical trials in advancing medicine and improving patient lives.
A Legacy Rooted in Evidence
The date commemorates the first documented clinical trial in history: James Lind’s 1747 study on scurvy treatment aboard a British naval ship. Today, the day serves as a global reminder that every modern medicine, therapy, or vaccine available to patients is the result of rigorous clinical research—and the indispensable participation of patients, researchers, and healthcare professionals.
Why Clinical Trials Matter
“First, we must understand what a clinical trial actually is,” Koraki explained in an interview with Live News. “It is the only process capable of proving whether a treatment or drug is both effective and safe. Without clinical trials, no medicine can gain regulatory approval—not by the U.S. FDA, not by the European Medicines Agency (EMA), nor by any other authority.”
She emphasized that every medication seen in pharmacies or hospitals has already been tested in clinical trials involving real patients. “When there are no existing treatment options—especially for rare diseases—the chance to join a clinical trial can be life-defining for a patient.”
Beyond Rare Diseases
Koraki noted that clinical research extends far beyond conditions with no current therapies. “Trials are ongoing across many fields—oncology, Alzheimer’s disease, ALS, Crohn’s disease, and more. Many of these studies are actively conducted in Greece.”
Pointing to tangible outcomes, she cited data showing that life expectancy in Europe has increased by decades over the past 60 years—largely due to advances driven by clinical trials. “HIV/AIDS was once fatal. Today, people living with HIV lead full, healthy lives—thanks to treatments developed through clinical research.”
A Partnership, Not a Process
Concluding her remarks, Koraki stressed a fundamental principle: “Clinical trials are not done *for* patients—they are done *with* them. Without patient participation, clinical trials simply cannot happen.” She acknowledged public hesitation but underscored the need for greater awareness and trust among citizens.